Literature DB >> 32232236

Fucoxanthin alleviates palmitate-induced inflammation in RAW 264.7 cells through improving lipid metabolism and attenuating mitochondrial dysfunction.

Siyu Li1, Xiaomeng Ren1, Yuandong Wang1, Jiangning Hu1, Haitao Wu1, Shuang Song1, Chunhong Yan2.   

Abstract

In this study, we aimed to examine the effects of fucoxanthin on inflammation triggered by palmitate in macrophages. Raw 264.7 cells were treated with palmitate with or without fucoxanthin co-treatment. Fucoxanthin greatly alleviated palmitate-induced decrease in cell viability and loss of mitochondrial membrane potential. Fucoxanthin also significantly attenuated the palmitate-induced transcriptional expression of Il-6, Il-1β, Tnfα and Nlrp3 inflammasomes and increased the expression of Tgfb. In addition, fucoxanthin decreased triglyceride accumulation induced by palmitate through enhancing the expression of Cpt1a, Pparg and other lipid metabolism genes. Inhibition of CPT1a by etomoxir attenuated the anti-inflammatory effect of fucoxanthin. Furthermore, fucoxanthin increased AMPK phosphorylation and AMPKa1 knockdown by its specific siRNA diminished protective function. In addition, fucoxanthin restored palmitate-mediated mitochondrial dysfunction and improved mitophagy-related gene expression. These findings suggest that fucoxanthin could attenuate free fatty acid-induced inflammation in macrophages through modulating lipid metabolism and mitigating mitochondrial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32232236     DOI: 10.1039/d0fo00442a

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  7 in total

Review 1.  A Systematic Review on Marine Algae-Derived Fucoxanthin: An Update of Pharmacological Insights.

Authors:  Md Mohibbullah; Md Nazmul Haque; Abdullah Al Mamun Sohag; Md Tahmeed Hossain; Md Sarwar Zahan; Md Jamal Uddin; Md Abdul Hannan; Il Soo Moon; Jae-Suk Choi
Journal:  Mar Drugs       Date:  2022-04-22       Impact factor: 6.085

Review 2.  Advances in Studies on the Pharmacological Activities of Fucoxanthin.

Authors:  Han Xiao; Jiarui Zhao; Chang Fang; Qi Cao; Maochen Xing; Xia Li; Junfeng Hou; Aiguo Ji; Shuliang Song
Journal:  Mar Drugs       Date:  2020-12-11       Impact factor: 5.118

Review 3.  Bioprospecting of microalgae metabolites against cytokine storm syndrome during COVID-19.

Authors:  Che Lah Wan Afifudeen; Kit Yinn Teh; Thye San Cha
Journal:  Mol Biol Rep       Date:  2021-11-09       Impact factor: 2.742

Review 4.  Anti-Inflammatory and Anticancer Effects of Microalgal Carotenoids.

Authors:  Javier Ávila-Román; Sara García-Gil; Azahara Rodríguez-Luna; Virginia Motilva; Elena Talero
Journal:  Mar Drugs       Date:  2021-09-23       Impact factor: 5.118

5.  Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4 Signaling Pathway.

Authors:  Jiena Ye; Jiawen Zheng; Xiaoxiao Tian; Baogui Xu; Falei Yuan; Bin Wang; Zuisu Yang; Fangfang Huang
Journal:  Mar Drugs       Date:  2022-03-25       Impact factor: 6.085

6.  Discoidin domain receptor 1a (DDR1a) confers 5-fluorouracil cytotoxicity in LoVo cell via PI3K/AKT/Bcl-2 pathway.

Authors:  Bin Xiong; Fei-Xue Song; Hui-Ling Chen; Xiao-Juan Wang; Zheng-Xu Jin; Ti-Yun Han; Yi Li; De-Kui Zhang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 7.  The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging.

Authors:  Allison K Meyers; Xuewei Zhu
Journal:  Cells       Date:  2020-07-30       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.